Table 2.
Association between SUA and lipids.
| Variables | Crude model | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| β a (95% CI) | P value | β a (95% CI) | P value | β a (95% CI) | P value | |
| TG (mmol/L) | ||||||
| SUA (per 1 mg/dL change) | 0.11 (0.10, 0.12) | <0.001 | 0.16 (0.15, 0.18) | <0.001 | 0.15 (0.14, 0.16) | <0.001 |
| Tertiles | ||||||
| T1 (<5.57) | Reference | Reference | Reference | |||
| T2 (5.57–8.39) | 0.18 (0.13, 0.23) | <0.001 | 0.31 (0.26, 0.36) | <0.001 | 0.26 (0.21, 0.31) | <0.001 |
| T3 (≥8.39) | 0.42 (0.37, 0.47) | <0.001 | 0.63 (0.58, 0.68) | <0.001 | 0.54 (0.48, 0.60) | <0.001 |
| P for trend | <0.001 | <0.001 | <0.001 | |||
|
| ||||||
| LDL-C (mmol/L) | ||||||
| SUA (per 1 mg/dL change) | 0.03 (0.02, 0.04) | <0.001 | 0.06 (0.06, 0.07) | <0.001 | 0.06 (0.05, 0.07) | <0.001 |
| Tertiles | ||||||
| T1 (<5.57) | Reference | Reference | Reference | |||
| T2 (5.57–8.39) | 0.06 (0.03, 0.10) | <0.001 | 0.15 (0.12, 0.18) | <0.001 | 0.13 (0.10, 0.16) | <0.001 |
| T3 (≥8.39) | 0.10 (0.07, 0.14) | <0.001 | 0.25 (0.21, 0.28) | <0.001 | 0.22 (0.18, 0.25) | <0.001 |
| P for trend | <0.001 | <0.001 | <0.001 | |||
|
| ||||||
| HDL-C (mmol/L) | ||||||
| SUA (per 1 mg/dL change) | −0.02 (−0.03, −0.02) | <0.001 | −0.02 (−0.02, −0.01) | <0.001 | −0.01 (−0.01, 0.01) | 0.083 |
| Tertiles | ||||||
| T1 (<5.57) | Reference | Reference | Reference | |||
| T2 (5.57–8.39) | −0.05 (−0.07, −0.04) | <0.001 | −0.05 (−0.06, −0.03) | <0.001 | −0.02 (−0.04, −0.01) | 0.021 |
| T3 (≥8.39) | −0.09 (−0.11, −0.07) | <0.001 | −0.07 (−0.09, −0.05) | <0.001 | −0.02 (−0.04, 0.01) | 0.107 |
| P for trend | <0.001 | <0.001 | 0.104 | |||
Abbreviations: CI, confidence interval; SUA, serum uric acid; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol. Crude model: unadjusted; model 1: adjusted for age, sex; model 2: adjusted for age, sex, smoking, alcohol use, stroke, diabetes, antihypertensive drugs, lipid-lowering drugs, glucose-lowering drugs, BMI, SBP, DBP, Hcy, FBG and eGFR. aIndicated effect sizes (β) were combined by Rubin's rule.